These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27905583)

  • 1. Intracellular water - an overlooked drug target? Cisplatin impact in cancer cells probed by neutrons.
    Marques MP; Batista de Carvalho AL; Sakai VG; Hatter L; Batista de Carvalho LA
    Phys Chem Chem Phys; 2017 Jan; 19(4):2702-2713. PubMed ID: 27905583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Look into the Mode of Action of Metal-Based Anticancer Drugs.
    Marques MPM; Batista de Carvalho ALM; Mamede AP; Dopplapudi A; Rudić S; Tyagi M; Garcia Sakai V; Batista de Carvalho LAE
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallodrug-protein interaction probed by synchrotron terahertz and neutron scattering spectroscopy.
    Batista de Carvalho LAE; Mamede AP; Batista de Carvalho ALM; Marques J; Cinque G; Rudić S; Marques MPM
    Biophys J; 2021 Aug; 120(15):3070-3078. PubMed ID: 34214537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic response to cisplatin-like drugs in human breast cancer cells probed by vibrational microspectroscopy.
    Batista de Carvalho AL; Pilling M; Gardner P; Doherty J; Cinque G; Wehbe K; Kelley C; Batista de Carvalho LA; Marques MP
    Faraday Discuss; 2016 Jun; 187():273-98. PubMed ID: 27063935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer drug impact on DNA - a study by neutron spectroscopy coupled with synchrotron-based FTIR and EXAFS.
    Batista de Carvalho ALM; Mamede AP; Dopplapudi A; Garcia Sakai V; Doherty J; Frogley M; Cinque G; Gardner P; Gianolio D; Batista de Carvalho LAE; Marques MPM
    Phys Chem Chem Phys; 2019 Feb; 21(8):4162-4175. PubMed ID: 30656331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic Targets in Osteosarcoma: Insights from Synchrotron-MicroFTIR and Quasi-Elastic Neutron Scattering.
    Marques MPM; Batista de Carvalho ALM; Mamede AP; Santos IP; García Sakai V; Dopplapudi A; Cinque G; Wolna M; Gardner P; Batista de Carvalho LAE
    J Phys Chem B; 2019 Aug; 123(32):6968-6979. PubMed ID: 31339317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water dynamics in MCF-7 breast cancer cells: a neutron scattering descriptive study.
    Martins ML; Dinitzen AB; Mamontov E; Rudić S; Pereira JEM; Hartmann-Petersen R; Herwig KW; Bordallo HN
    Sci Rep; 2019 Jun; 9(1):8704. PubMed ID: 31213625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts.
    Kasherman Y; Sturup S; Gibson D
    J Med Chem; 2009 Jul; 52(14):4319-28. PubMed ID: 19537717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inelastic incoherent neutron scattering measurements of intact cells and tissues and detection of interfacial water.
    Ford RC; Ruffle SV; Ramirez-Cuesta AJ; Michalarias I; Beta I; Miller A; Li J
    J Am Chem Soc; 2004 Apr; 126(14):4682-8. PubMed ID: 15070386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutron scattering measurements of intact cells show changes after heat shock consistent with an increase in molecular crowding.
    Ford RC; Ruffle SV; Michalarias I; Beta I; Ramirez-Cuesta AJ; Li J
    J Mol Recognit; 2004; 17(5):505-11. PubMed ID: 15362111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance.
    Marques MP; Gianolio D; Cibin G; Tomkinson J; Parker SF; Valero R; Pedro Lopes R; Batista de Carvalho LA
    Phys Chem Chem Phys; 2015 Feb; 17(7):5155-71. PubMed ID: 25601325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell death induced in a human glioblastoma cell line by p(65)+Be neutrons combined with cisplatin.
    Benzina S; Fischer B; Miternique-Grosse A; Dufour P; Denis JM; Bergerat JP; Gueulette J; Bischoff P
    Life Sci; 2006 Jul; 79(6):513-8. PubMed ID: 16516239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational and vibrational study of platinum(II) anticancer drugs: cis-diamminedichloro-platinum(II) as a case study.
    Amado AM; Fiuza SM; Marques MP; Batista de Carvalho LA
    J Chem Phys; 2007 Nov; 127(18):185104. PubMed ID: 18020667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
    Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
    Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin binds to human copper chaperone Cox17: the mechanistic implication of drug delivery to mitochondria.
    Zhao L; Cheng Q; Wang Z; Xi Z; Xu D; Liu Y
    Chem Commun (Camb); 2014 Mar; 50(20):2667-9. PubMed ID: 24473407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pressure on the low-frequency vibrational modes of lysozyme and water: a complementary inelastic neutron scattering and molecular dynamics simulation study.
    Lerbret A; Hédoux A; Annighöfer B; Bellissent-Funel MC
    Proteins; 2013 Feb; 81(2):326-40. PubMed ID: 23011876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside-lipid-based nanoparticles for cisplatin delivery.
    Khiati S; Luvino D; Oumzil K; Chauffert B; Camplo M; Barthélémy P
    ACS Nano; 2011 Nov; 5(11):8649-55. PubMed ID: 21961944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor targeting using polyamidoamine dendrimer-cisplatin nanoparticles functionalized with diglycolamic acid and herceptin.
    Kesavan A; Ilaiyaraja P; Sofi Beaula W; Veena Kumari V; Sugin Lal J; Arunkumar C; Anjana G; Srinivas S; Ramesh A; Rayala SK; Ponraju D; Venkatraman G
    Eur J Pharm Biopharm; 2015 Oct; 96():255-63. PubMed ID: 26277659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin enhances the cytotoxicity of fast neutrons in a murine lymphoma cell line.
    Fischer B; Benzina S; Ganansia-Leymarie V; Denis JM; Bergerat JP; Dufour P; Gueulette J; Bischoff P
    Can J Physiol Pharmacol; 2004 Feb; 82(2):140-5. PubMed ID: 15052295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant.
    Chau Q; Stewart DJ
    Cancer Chemother Pharmacol; 1999; 44(3):193-202. PubMed ID: 10453720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.